WOCKPHARMABSEWockhardt LtdMediumNeutral
Announced Mon, 4 May · 18:34 IST

Change in Senior Management Personnel.

Management Changes View source PDF

WOCKPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+17.4%1-day move
₹1431.00
prior close
₹1500.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.8+4.6+4.1+2.4+17.4+14.0+12.5+13.6+9.7+8.0+19.9+34.5+34.0
Up moveDown movePending
AI summary

Wockhardt Ltd has designated three existing senior employees as Senior Management Personnel (SMP) effective May 4, 2026. The three individuals are Ms. Annapurna Das (President, India Business & Emerging Markets), Mr. Om Narayan (Senior Vice President, Biotech Research Centre), and Mr. Sunil Soni (Senior Vice President, Biotechnology). All three are experienced pharmaceutical and biotech leaders with 26-30 years of experience at global companies like Takeda, Sanofi, Mylan, and Serum Institute of India. This appears to be an internal designation exercise rather than new hires, bringing key operational leaders under the SMP category as required under SEBI listing regulations.

Likely market impact

This is a routine compliance filing with minimal direct impact on shareholders. The designation of experienced biotech and pharmaceutical leaders to SMP roles could signal strengthened senior management depth in Wockhardt's key business segments, though no immediate material impact on stock price is expected.